release one major TV ad, costs about $5-10 million, 4 weeks later they get about 225,000 scripts. Multiply that by $2000-3,000 per prescription, $500,000,000 in revenue. Not a bad return!
their morale is all time low and they are caving, something is gonna give and this will fly.
a little bird told me, SNY is buying mnkd after their trial run with AFrezza. ONLY a group of docs have been prescribing AFrezza. The rest of the half million docs can prescribe but if they don't know Afrezza, they can't prescribe.
the trades seem to suggest they are fighting tooth and nail to find shares. Still alot of manipulations. But you are right, no urgency yet; also no shares to buy.
congrats to longs. I was hoping this would go the distance. But I will take a 5 bagger.
i only see northern Cal Kaiser from google search. Kaiser is probably the biggest managed care in America but is other kaiser regions covered too?
looks like they blew their wad for nothing. it went back up. Someone has been sitting around for nearly 3-4 weeks, just collecting cheap shares.
Longs who held after FDA approval see Afrezza as a blockbuster. This is a slow launch without any PR or advertisement, and they haven't even manufactured enough Afrezza to meet any expectation of high volume. Thus, you have to wait for consumer advertisments and full launch. In the mean time, Afrezza is gaining traction, increasing scripts by factor of 50-100%.
Shorts on the other hand, was 70 million shares in the hole before FDA approval, so they hoped that Afrezza would get killed by the FDA. But it didn't, so now we have manipulation with 40+ more million shares used to manipulate price down. I think they dug themselves into their own graves.
The shorts attacked and we will see soon how many more shares they burned trying to control the price, from the last two weeks of trading. This worked well into SNY buying; they are getting a bargain compared to buyout price. In a few weeks, we will see what the shorts actually have been doing since Middle of May.
if it stays in the 4's, it is time to add more shares. We are at the bottom, time will get better and better with scripts#
you should short sell everything above zero then. Becareful, commision may cost more than share price.
out of 52 states, they got 4 scripts from each state? Just how many docs know about AFrezza? Did they send out 10 SNY reps to sell Afrezza?
This tells me that the number of docs prescribing Afrezza has been the same for 2 months. Something smells fishy here.
it doesn't mean anyuthing, looke at the share price and it's dirt cheap, so he changed his mind. Any logical person would, take it as that! don't read too much into it.
BTW that $1 million was at market (so the price is what they could get for Afrezza). Mankind produced $7.1 million at COST, at market would be much much higher.
that $1 million sell was only in the US. Perhaps they are stocking away for Euro or Asian launch, and samples all over the world. Spread the samples across the globe and get the docs familiarized before massive advertisement campaign to drive the patients to the docs.